Diseases, Conditions, Syndromes

ICAAC: Moxifloxacin regimens are not noninferior for TB

(HealthDay)—For patients with uncomplicated, smear-positive pulmonary tuberculosis, moxifloxacin-containing regimens over four months are not noninferior to a control regimen, according to a study published online Sept. ...

Oncology & Cancer

Moxifloxacin monotherapy equivalent to antibiotic combo

(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who ...

Diseases, Conditions, Syndromes

Scientists: Novel TB drug combo passes first test

Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two main drugs.

page 1 from 2